Salt Form Screening

Salt Form Screening

Salt form screening is a pivotal strategy in solid-state chemistry used to modify the physicochemical properties of Active Pharmaceutical Ingredients (APIs) without altering their pharmacological activity. For ionizable drug candidates, selecting the optimal salt form can significantly enhance solubility, dissolution rate, bioavailability, and physical stability. BOC Sciences offers comprehensive salt screening services, utilizing expert solid-state characterization. We help clients identify the most developable crystalline forms for their drug candidates, resolving challenges related to hygroscopicity, polymorphism, and processability to accelerate early-stage drug development.

BOC Sciences Solid State Screening Services

Polymorph Screening

  • Crystal Lattice Investigation: Comprehensive study of different crystal lattice arrangements to identify unique crystalline phases.
  • Form Identification: Discovery and characterization of thermodynamically stable anhydrous forms, hydrates, solvates, and metastable polymorphs.

Salt Screening

  • Physicochemical Modification: Strategic selection of counter-ions to modify properties of ionizable APIs without altering pharmacological activity.
  • Performance Enhancement: Significant improvement of aqueous solubility, dissolution rate, and oral bioavailability.

Cocrystal Screening

  • Ligand Screening: Screening for molecular complexes formed with neutral co-formers (ligands) rather than ionic interactions.
  • Property Optimization: Optimization of melting point, stability, and solubility, particularly for non-ionizable drug candidates.

Amorphous Screening

  • Solid Dispersion Study: Development and evaluation of amorphous solid dispersions (ASDs) to stabilize high-energy disordered forms.
  • Solubility Improvement: Maximizing kinetic solubility for poorly water-soluble compounds (BCS Class II/IV).
Need to Improve API Solubility and Stability?

BOC Sciences delivers expert salt form screening to optimize your drug's solid-state properties, ensuring a smoother path to formulation.

Request a Quote

Salt Screening & Crystallization Methods

Solvent Methods

Solvent-Assisted Methods

  • Reaction Crystallization
  • Evaporation Crystallization
  • Cooling Crystallization
  • Solvent-Antisolvent Precipitation
Slurry Conversion

Slurry Conversion

  • Suspension Stirring
  • Slurry Maturation
  • Thermodynamic Equilibration
  • Competitive Slurrying
Thermal Treatment

Thermal Treatment

  • Melt Crystallization
  • Thermal Cycling
  • Hot Stage Experiments
  • Desolvation/Dehydration
Mechanochemical

Mechanochemical Methods

  • Neat Grinding
  • Ball Milling
  • Liquid-Assisted Grinding (LAG)
  • Resonant Acoustic Mixing
Crystal Growth

Crystal Growth Methods

  • Sublimation
  • Vapor Diffusion
  • Liquid-Liquid Diffusion (Layering)
  • Gas Phase Growth
Advanced Tech

Advanced Technologies

  • Spray Drying & Freeze Drying
  • Supercritical Anti-Solvent (SAS)
  • Ultrasound-Induced Crystallization

Supported Molecules for Salt Screening

BOC Sciences applies rational salt selection strategies to a wide range of ionizable compounds, customizing the counter-ion library based on the API's acid-base properties.

Weakly Basic Compounds

  • Inorganic Acids (HCl, Sulfate)
  • Organic Acids (Mesylate, Tosylate)
  • Dicarboxylic Acids (Fumarate, Succinate)
  • Hydroxy Acids (Citrate, Tartrate)

Weakly Acidic Compounds

  • Alkali Metals (Sodium, Potassium)
  • Alkaline Earth Metals (Calcium, Magnesium)
  • Organic Bases (Tromethamine)
  • Amino Acids (Lysine, Arginine)

Challenging Candidates

  • Zwitterionic compounds
  • Poorly crystalline free forms
  • Hydrate/Solvate prone APIs
  • BCS Class II & IV molecules

Start Your Salt Screening Project

Submit your compound details, and our solid-state experts will design a tailored screening protocol to optimize your compound's performance.

Submit Your Request

BOC Sciences Salt Screening Workflow

Consultation

1Project Consultation & Sample Reception

We initiate the project by communicating with clients to understand specific development goals (e.g., solubility, stability) and receiving the compound samples to define the project scope.

Assessment

2Assessment & Counter-ion Selection

We evaluate the compound's pKa, solubility, and structure to select a scientifically relevant library of counter-ions, ensuring a sufficient pKa difference (ΔpKa > 2) for stable salt formation.

Characterization

3Hit Identification & Profiling

Hits are analyzed by XRPD and PLM. Leading candidates undergo secondary profiling (DSC, TGA, DVS, Solubility) to assess stability and hygroscopicity.

Selection

4Recommendation & Reporting

We deliver a comprehensive report ranking the salt forms based on developability criteria, recommending the optimal form for scale-up and formulation.

Solutions for Solid-State Challenges

01

Bioavailability Enhancement

Poor aqueous solubility is a major hurdle in drug development. Our salt screening services identify high-solubility salt forms that significantly improve dissolution rates, thereby enhancing oral absorption and bioavailability for BCS Class II compounds.

02

Stability Optimization

We address physical and chemical instability issues. By selecting the right counter-ion, we can increase the melting point to prevent melting during processing or select non-hygroscopic forms to maintain stability under humid storage conditions.

03

Manufacturability Improvement

Some APIs exhibit poor flow, stickiness, or difficult filtration properties. We screen for salts with optimal crystal habit (e.g., prisms vs. needles) to improve powder flow properties, bulk density, and tableting performance.

04

Purification via Crystallization

Salt formation is an excellent method for purification. We design screenings to find salt forms that naturally reject process impurities during crystallization, providing a high-purity solid form as an alternative to complex chromatographic purification.

Optimize Your Drug's Solid Form Today!

Partner with BOC Sciences to leverage our solid-state chemistry expertise. We provide rapid, data-driven salt screening to transform your problematic API into a developable, high-quality drug substance.

Request a Quote

Why Choose BOC Sciences for Salt Screening?

Comprehensive Characterization

We go beyond basic identification. Our integrated analytical suite (XRPD, DSC, TGA, DVS, NMR) provides a complete picture of the solid-state properties of every candidate to support critical decision-making.

Developability Focus

Our screening is driven by development needs. We prioritize salts that are not only stable and soluble but also manufacturable, scalable, and chemically compatible with common excipients.

Experienced Scientific Team

Our solid-state chemists have extensive experience in crystallography and pre-formulation. We provide expert interpretation of complex data, guiding you to the best decision for your program.

Seamless Scale-up

We ensure a smooth transition from lab-scale screening to process development. By integrating solid-state science with process chemistry, we validate that your selected form remains robust during scale-up.

Applications in Pharmaceutical Development

Improving Physicochemical Properties

  • Solubility & Dissolution Enhancement
  • Hygroscopicity Reduction
  • Thermal & Chemical Stability
  • Bioavailability Optimization

Patent Landscape & IP Strategy

  • Patent Life Cycle Extension
  • IP Portfolio Fortification
  • Patent Circumvention (FTO)
  • Unique Crystalline Form Claims

Formulation & Quality Control

  • Processability (Flow & Tableting)
  • Impurity Rejection via Crystallization
  • Critical Quality Attributes (CQAs)
  • Batch-to-Batch Consistency

Salt Screening Case Studies

Client Needs: A client had a promising BCS Class II weak base with extremely low aqueous solubility (< 1 µg/mL), resulting in poor oral bioavailability in animal models. They needed a salt form to improve dissolution.

Challenges: The free base was highly crystalline and difficult to dissolve in common screening solvents. Initial attempts with simple mineral acids (HCl) resulted in hygroscopic salts that were difficult to handle.

Solution: Leveraging our rational counter-ion selection algorithm based on pKa differences, BOC Sciences executed a targeted high-throughput screening utilizing a diverse range of organic sulfonic acids. By systematically optimizing solvent polarity and supersaturation levels, we successfully isolated highly crystalline Mesylate and Tosylate salts, confirming their stoichiometry and purity through rigorous solid-state characterization (XRPD, NMR) to ensure superior developability.

Outcome: The Mesylate salt demonstrated a 60-fold increase in aqueous solubility and a significantly faster dissolution rate compared to the free base. The client selected this form for further development, achieving target exposure levels in subsequent PK studies.

Client Needs: A pharmaceutical company was developing an HCl salt of a drug candidate, but the material was deliquescent at RH > 50%, requiring expensive moisture-controlled manufacturing suites.

Challenges: The drug had limited counter-ion options due to pKa constraints. The client needed a stable, non-hygroscopic alternative without losing the solubility advantage of the HCl salt.

Solution: Our solid-state experts employed a crystal engineering approach, specifically screening dicarboxylic acids known to promote dense crystal packing networks. Through iterative crystallization experiments and real-time Dynamic Vapor Sorption (DVS) profiling, we identified a unique 1:1 Fumarate salt structure where the lattice energy landscape favored exceptional physical stability, effectively blocking moisture ingress even under elevated humidity conditions.

Outcome: The Fumarate salt was successfully scaled up. It maintained good solubility while solving the moisture stability issue, allowing the client to manufacture the drug product in standard facilities, reducing costs.

Client Needs: During the scale-up of a Citrate salt, a client observed batch-to-batch variability in melting point and dissolution, suspecting uncontrolled polymorphism.

Challenges: The system was prone to forming metastable polymorphs and solvates depending on the cooling rate and solvent composition. The client needed a robust process to produce the thermodynamically stable form consistently.

Solution: To definitively resolve the phase capability, BOC Sciences conducted exhaustive thermodynamic mapping using competitive slurry experiments and solvent-mediated phase transformation studies across multiple temperature ranges. We constructed a precise energy-temperature diagram to identify the true stable polymorph and developed a controlled seeding strategy that effectively suppresses metastable zones, ensuring process robustness.

Outcome: We developed a controlled crystallization process seeded with the stable polymorph. This ensured consistent production of the desired form, eliminating batch variability and securing the solid-state integrity of the API.

Frequently Asked Questions

Frequently Asked Questions

Still have questions?

Contact Us

Client Reviews: Solid State Services

Expert Services Supporting Formulation Design and Screening

Have a Question or Issue?

If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.

Online Inquiry
Verification code